Financial Performance - Atomera reported a net loss of $4.6 million, or $0.17 per share, for Q3 2024, an improvement from a net loss of $5.0 million, or $0.20 per share, in Q3 2023[3] - Adjusted EBITDA for Q3 2024 was a loss of $3.9 million, compared to a loss of $4.3 million in Q3 2023[3] - Total net loss for the nine months ended September 2024 was $(13,778) thousand, compared to $(15,210) thousand for the same period in 2023[12] - Non-GAAP EBITDA for September 2024 was $(3,881) thousand, compared to $(4,292) thousand in September 2023, indicating a reduction in losses[12] - The company continues to focus on reducing net losses and improving EBITDA metrics in future quarters[12] Cash and Investments - The company had $17.3 million in cash, cash equivalents, and short-term investments as of September 30, 2024, down from $19.5 million as of December 31, 2023[4] Operating Expenses - Total operating expenses for Q3 2024 were $4.8 million, slightly lower than $4.6 million in Q2 2024[11] - Research and development expenses increased to $2.8 million in Q3 2024 from $2.6 million in Q2 2024[11] - Depreciation and amortization expenses were $12 thousand for the three months ended September 2024, down from $20 thousand in the same period last year[12] - Stock-based compensation decreased to $907 thousand in September 2024 from $1,041 thousand in September 2023[12] - Interest expense for September 2024 was $30 thousand, a decrease from $47 thousand in September 2023[12] - Interest income for September 2024 was $(176) thousand, slightly improved from $(177) thousand in September 2023[12] - Accretion income for September 2024 was $(59) thousand, compared to $(112) thousand in September 2023[12] - Other income, net, was $(72) thousand for both September 2024 and September 2023, indicating no change[12] Market and Collaborations - Atomera announced a collaboration with Sandia National Laboratories to address GaN manufacturing challenges, indicating potential market expansion[2] - The company is optimistic about accelerating engagements in various segments, which may lead to new licenses and joint development agreements[2] Share Information - The total number of shares outstanding was 28.3 million as of September 30, 2024[4] Gross Margin - Atomera's gross margin for Q3 2024 was reported at 19%[11] Early-Stage Risks - The company has recognized minimal engineering services and licensing revenues to date, highlighting the risks of being an early-stage enterprise[7]

Atomera Incorporated (NASDAQ:ATOM) Q2 2024 Results Conference Call July 30, 2024 5:00 PM ET Company Participants Mike Bishop - Investor Relations Scott Bibaud - President and Chief Executive Officer Frank Laurencio - Chief Financial Officer Conference Call Participants Richard Shannon - Craig Hallam Mike Bishop Hello, everyone and welcome to Atomera’s Second Quarter Fiscal Year 2024 Update Call. I’d like to remind everyone that this call and webinar are being recorded, and a replay will be available on Atom ...

Revenue and Costs - Revenue for the three and six months ended June 30, 2024, was approximately $72,000 and $90,000 respectively, with no revenue recorded during the same periods in 2023[77] - Cost of revenue for the three and six months ended June 30, 2024, was approximately $74,000 and $107,000 respectively, with no cost recorded during the same periods in 2023[79] Operating Expenses - Operating expenses for the three months ended June 30, 2024, totaled approximately $4.6 million, a decrease from $5.4 million in 2023, while for the six months, expenses were approximately $9.6 million compared to $10.5 million in 2023[80] - Research and development expenses for the three months ended June 30, 2024, were approximately $2.6 million, a decrease of 19% from $3.2 million in 2023, and for the six months, expenses were approximately $5.4 million, down 13% from $6.2 million in 2023[81][82] - General and administrative expenses for the three months ended June 30, 2024, were approximately $1.8 million, an increase of 3% from 2023, while for the six months, expenses were approximately $3.6 million, up 4% from 2023[83][84] - Selling and marketing expenses for the three months ended June 30, 2024, were approximately $207,000, a decrease of 47% from $393,000 in 2023, and for the six months, expenses were approximately $557,000, down 29% from $782,000 in 2023[85] Income and Cash Flow - Interest income for the three months ended June 30, 2024, was approximately $185,000, compared to $152,000 in 2023, and for the six months, it was approximately $390,000 versus $351,000 in 2023[87] - Net cash used in operating activities for the six months ended June 30, 2024, was approximately $7.3 million, compared to $8.2 million in 2023[89] - As of June 30, 2024, the company had cash and cash equivalents of approximately $14.5 million and short-term investments of approximately $3.8 million[92] Future Outlook and Capital Requirements - The company believes its available working capital is sufficient to fund forecasted working capital requirements for at least the next 12 months[93] - Future capital requirements will depend on the successful commercialization of MST technology and potential collaborations or acquisitions[93] - If sufficient revenue from license fees and royalties is not generated, the company may need to raise additional capital through various financing sources[93] Compliance and Controls - Management evaluated the effectiveness of disclosure controls and procedures, concluding they were effective as of June 30, 2024[95] - There have been no changes to critical accounting estimates from the Annual Report on Form 10-K for the year ended December 31, 2023[94] - No changes to internal controls over financial reporting have occurred that materially affect the company's reporting[96] Licensing Agreement - The company entered into a license agreement with ST Microelectronics in April 2023, which is expected to generate royalties on MST-enabled products once milestones are met[73]

Financial Performance - Atomera reported a net loss of $4.4 million, or $0.16 per share, for Q2 2024, an improvement from a net loss of $5.2 million, or $0.21 per share, in Q2 2023[3] - Adjusted EBITDA loss for Q2 2024 was $3.6 million, compared to a loss of $4.3 million in Q2 2023[3] - Net loss for the three months ended June 30, 2024, was $4.361 million, compared to a net loss of $5.152 million for the same period in 2023, representing a 15.3% improvement[14] - Non-GAAP EBITDA for the six months ended June 30, 2024, was a loss of $7.623 million, compared to a loss of $8.530 million for the same period in 2023, indicating a 10.6% reduction in losses[14] - The total net loss for the six months ended June 30, 2024, was $(9.183 million), compared to $(10.171 million) for the same period in 2023, showing an 9.7% decrease in losses[14] Cash and Investments - The company had $18.3 million in cash, cash equivalents, and short-term investments as of June 30, 2024, down from $19.5 million at the end of 2023[3] - Stock-based compensation for the three months ended June 30, 2024, was $987,000, slightly down from $1.030 million in the same period last year[14] - Interest income decreased to $(185,000) for the three months ended June 30, 2024, compared to $(152,000) for the same period in 2023[14] - Interest expense for the three months ended June 30, 2024, was $35,000, a decrease from $51,000 in the same period in 2023[14] - Other income, net, for the three months ended June 30, 2024, was $(72,000), with no other income reported in the same period last year[14] - Accretion income for the three months ended June 30, 2024, was $(47,000), slightly better than $(107,000) reported in the same period last year[14] Operating Expenses - Research and development expenses for Q2 2024 were $2.6 million, compared to $3.2 million in Q2 2023[13] - Total operating expenses for Q2 2024 were $4.6 million, down from $5.4 million in Q2 2023[13] - Depreciation and amortization expenses for the three months ended June 30, 2024, were $13,000, down from $20,000 in the same period last year[14] Business Development - The company announced the availability of an MST RFSOI wafer substrates solution for cellular communication products[1] - A new VP of Marketing and Business Development was appointed, indicating a focus on enhancing business development efforts[1] - Atomera submitted its first proposal under the Chips and Sciences Act, aiming to leverage government support for semiconductor technology[1] - The company is on track with its lead customer towards production, indicating potential future revenue growth[2] Shares Outstanding - Total shares outstanding as of June 30, 2024, were 27.6 million[3]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2024. or ☐ Transition Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the transition period from __________ to __________ Commission file number: 001-37850 ATOMERA INCORPORATED (Exact name of registrant as specified in its charter) | --- | --- | ...

Atomera Incorporated (NASDAQ:ATOM) Q1 2024 Earnings Conference Call April 25, 2024 5:00 PM ET Company Participants Mike Bishop - Investor Relations Scott Bibaud - President and Chief Executive Officer Frank Laurencio - Chief Financial Officer Conference Call Participants Richard Shannon - Craig-Hallum Mike Bishop Hello, everyone and welcome to Atomera’s First Quarter Fiscal Year 2024 Update Call. I’d like to remind everyone that this call and webinar are being recorded, and a replay will be available on Ato ...

Exhibit 99.1 Atomera Provides First Quarter 2024 Results LOS GATOS, Calif. April 25, 2024 Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2024. Recent Company Highlights · Strong progress with customers in all four market focus segments · Record number of commercial proposals in the last three months · Promising GaN results in a new product category, Compou ...

Hypergrowth stocks are some of the most captivating, yet perilous, investments out there. On one hand, companies experiencing hypergrowth can deliver enormous returns for early investors. However, many of these high-flyers have slowed down or racked up substantial losses, forcing them to take dilutive measures like secondary offerings just to stay afloat. This can result in shareholder value being decimated.Yet, there are still some diamonds in the rough. Many profitable hypergrowth companies continue to gr ...

da-kuk Atomera Incorporated (NASDAQ:ATOM) recently reported significant exposure to the AI industry, 5G, and the IoT sector, which may, in my view, accelerate net sales growth. Taking into account the number of customer engagements expected for the year 2024, the business connections of ATOM's CEO, and total amount of cash standing in the balance sheet, ATOM does look like a buy. There are risks from failed sales and marketing efforts, failed partnerships with manufacturers, or lack of sufficient financing ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37850 ATOMERA INCORPORATED (Exact name of registrant as specified in its charter) Delaware 30-0509586 (State or Other jurisdiction ...